BTG3 and anemia: In our cohort, patients with SVN had a shorter duration between symptom onset and nerve biopsy, more systemic symptoms and were more likely to have anaemia, raised inflammatory markers and positive serology for ANA, ANCA or RF than patients with NSVN.